Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

David M Berman

Head Of R&D at Immunocore Holdings plc (IMCR)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $7.4M

Reported trades

Filed Stock Type Shares Price Value Since
Feb 19SEC IMCRImmunocore Holdings plc Sell 5,9655,859 held (−50%) $32.35 $193K -9.1%
Dec 8SEC IMCRImmunocore Holdings plc Sell Plan 31,341 $40.26 $1.3M -27.0%
Dec 8SEC IMCRImmunocore Holdings plc Sell Plan 572 $40.14 $23K -26.8%
Dec 1SEC IMCRImmunocore Holdings plc Sell Plan 69,404 $40.12 $2.8M -26.7%
Dec 1SEC IMCRImmunocore Holdings plc Sell Plan 5,521 $40.09 $221K -26.7%
Nov 26SEC IMCRImmunocore Holdings plc Sell Plan 100 $40.00 $4K -26.5%
Nov 26SEC IMCRImmunocore Holdings plc Sell Plan 18,020 $40.03 $721K -26.6%
Oct 2SEC IMCRImmunocore Holdings plc Sell Plan 61,849 $35.23 $2.2M -16.6%
  • Sell

    Head Of R&D David M Berman sold $193K of IMCR at $32.35 — cuts the stake by 50%.

  • Sell

    Head Of R&D David M Berman sold $1.3M of IMCR at $40.26 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Head Of R&D David M Berman sold $23K of IMCR at $40.14 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Head Of R&D David M Berman sold $2.8M of IMCR at $40.12 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Head Of R&D David M Berman sold $221K of IMCR at $40.09 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Head Of R&D David M Berman sold $4K of IMCR at $40.00 — pre-scheduled 10b5-1 plan sale.